These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 3953353)

  • 61. An overview of antiarrhythmic drug management of electrical storm.
    Kowey PR
    Can J Cardiol; 1996 Apr; 12 Suppl B():3B-8B; discussion 27B-28B. PubMed ID: 8616726
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Multicentre randomized trial of sotalol vs amiodarone for chronic malignant ventricular tachyarrhythmias. Amiodarone vs Sotalol Study Group.
    Eur Heart J; 1989 Aug; 10(8):685-94. PubMed ID: 2676535
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pediatric use of intravenous amiodarone: efficacy and safety in critically ill patients from a multicenter protocol.
    Perry JC; Fenrich AL; Hulse JE; Triedman JK; Friedman RA; Lamberti JJ
    J Am Coll Cardiol; 1996 Apr; 27(5):1246-50. PubMed ID: 8609351
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation. The Intravenous Amiodarone Multicenter Investigators Group.
    Kowey PR; Levine JH; Herre JM; Pacifico A; Lindsay BD; Plumb VJ; Janosik DL; Kopelman HA; Scheinman MM
    Circulation; 1995 Dec; 92(11):3255-63. PubMed ID: 7586312
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clinical pharmacology of amiodarone.
    Marcus FI
    Ann N Y Acad Sci; 1984; 427():112-26. PubMed ID: 6378011
    [No Abstract]   [Full Text] [Related]  

  • 66. Intravenous amiodarone for acute heart rate control in the critically ill patient with atrial tachyarrhythmias.
    Clemo HF; Wood MA; Gilligan DM; Ellenbogen KA
    Am J Cardiol; 1998 Mar; 81(5):594-8. PubMed ID: 9514456
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Suppression of arrhythmias within hours after a single oral dose of amiodarone and relation to plasma and myocardial concentrations.
    Escoubet B; Coumel P; Poirier JM; Maison-Blanche P; Jaillon P; Leclercq JF; Menasche P; Cheymol G; Piwnica A; Lagier G
    Am J Cardiol; 1985 Mar; 55(6):696-702. PubMed ID: 3976511
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pharmacokinetics, antiarrhythmic effects, and tissue concentrations of amiodarone and desethylamiodarone in dogs with acute coronary artery occlusion.
    Somani P; Simon VA; McManus K
    Can J Cardiol; 1985 Jan; 1(1):56-65. PubMed ID: 3850764
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Hemodynamic effects of intravenous amiodarone.
    Kosinski EJ; Albin JB; Young E; Lewis SM; LeLand OS
    J Am Coll Cardiol; 1984 Sep; 4(3):565-70. PubMed ID: 6470338
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Amiodarone--application and clinical pharmacology in atrial fibrillation and other arrhythmias.
    Anastasiou-Nana M; Levis GM; Moulopoulos SD
    Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):229-35. PubMed ID: 6746145
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Electrophysiologic effects of chronic amiodarone therapy in patients with ventricular arrhythmias.
    Finerman WB; Hamer A; Peter T; Weiss D; Mandel WJ
    Am Heart J; 1982 Nov; 104(5 Pt 1):987-96. PubMed ID: 7137016
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Amiodarone therapy in childhood: efficacy and side effects].
    Vignati G; Danzi GB; Austoni P; Fancini P; Mascarello M; Figini A
    G Ital Cardiol; 1985 Aug; 15(8):786-94. PubMed ID: 2935440
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Efficacy of amiodarone for refractory supraventricular tachyarrhythmias.
    Graboys TB; Podrid PJ; Lown B
    Am Heart J; 1983 Oct; 106(4 Pt 2):870-6. PubMed ID: 6613832
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Dose-ranging study of intravenous amiodarone in patients with life-threatening ventricular tachyarrhythmias. The Intravenous Amiodarone Multicenter Investigators Group.
    Scheinman MM; Levine JH; Cannom DS; Friehling T; Kopelman HA; Chilson DA; Platia EV; Wilber DJ; Kowey PR
    Circulation; 1995 Dec; 92(11):3264-72. PubMed ID: 7586313
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Amiodarone for long-term management of patients with hypertrophic cardiomyopathy.
    McKenna WJ; Harris L; Rowland E; Kleinebenne A; Krikler DM; Oakley CM; Goodwin JF
    Am J Cardiol; 1984 Oct; 54(7):802-10. PubMed ID: 6541429
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Efficacy of amiodarone in the Wolff-Parkinson-White syndrome with rapid ventricular response via accessory pathway during atrial fibrillation.
    Kappenberger LJ; Fromer MA; Steinbrunn W; Shenasa M
    Am J Cardiol; 1984 Aug; 54(3):330-5. PubMed ID: 6465013
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Clinical pharmacology and therapeutic applications of the antiarrhythmic agent amiodarone.
    Marcus FI; Fontaine GH; Frank R; Grosgogeat Y
    Am Heart J; 1981 Apr; 101(4):480-93. PubMed ID: 7010975
    [No Abstract]   [Full Text] [Related]  

  • 78. Clinical antiarrhythmic effects of amiodarone in patients with resistant paroxysmal tachycardias.
    Ward DE; Camm AJ; Spurrell RA
    Br Heart J; 1980 Jul; 44(1):91-5. PubMed ID: 7426166
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Intravenous amiodarone for life-threatening tachyarrhythmias in children and young adults.
    Perry JC; Knilans TK; Marlow D; Denfield SW; Fenrich AL; Friedman RA
    J Am Coll Cardiol; 1993 Jul; 22(1):95-8. PubMed ID: 8509571
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Intravenous amiodarone in atrial fibrillation complicating myocardial infarction.
    Blandford RL; Crampton J; Kudlac H
    Br Med J (Clin Res Ed); 1982 Jan; 284(6308):16-7. PubMed ID: 6797619
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.